GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SXTP · Jun 30, 2025

60 DEGREES PHARMACEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001554855-25-001009General Corporate
Debt relative to revenue75thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.debt_to_revenue

148.61% · OPTIONAL · VALID

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

46.89% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1436.74% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-19.24% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure88thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

792.04% · OPTIONAL · VALID

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

50.41% · CORE · NOT_ENOUGH_HISTORY

Operating margin50thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

-1590.01% · CORE · VALID

R&D intensity0thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

247.58% · OPTIONAL · VALID

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

77.89% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
91.71%
Current
148.61%
Delta
56.90%
Capex Intensity Increased
Previous
1.64%
Current
46.89%
Delta
45.25%
Cash Generation Decreased
Previous
-976.67%
Current
-1436.74%
Delta
-460.07%
Growth Decreased
Previous
40.43%
Current
-19.24%
Delta
-59.67%
Inventory Pressure Increased
Previous
472.78%
Current
792.04%
Delta
319.26%
Margin Decreased
Previous
55.20%
Current
50.41%
Delta
-4.79%
Profitability Decreased
Previous
-1168.36%
Current
-1590.01%
Delta
-421.65%
R And D Intensity Decreased
Previous
249.23%
Current
247.58%
Delta
-1.65%
Sbc Intensity Decreased
Previous
114.19%
Current
77.89%
Delta
-36.30%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.